Literature DB >> 15542121

Wear particulate and osteolysis.

Stuart Goodman1.   

Abstract

Total joint replacements of the hip and knee are generally highly successful, with satisfactory longevity and clinical results. Using modern biocompatible materials, optimal component design, and meticulous surgical technique, survivorship of cemented or cementless joint replacements is approximately 15 years with more than a 90% probability. The host's biologic response is critical to implant longevity. Particulate disease refers to the host's adverse biologic response to wear debris and byproducts generated from the prosthesis. Initially, emphasis was placed on particulate polymethylmethacrylate (cement disease), but more recently polyethylene wear debris has been underscored. Debris from several materials in sufficient quantities and physicochemical forms, however, can generate an inflammatory cascade resulting in periprosthetic bone destruction (osteolysis), jeopardizing long-term success of the implant.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15542121     DOI: 10.1016/j.ocl.2004.06.015

Source DB:  PubMed          Journal:  Orthop Clin North Am        ISSN: 0030-5898            Impact factor:   2.472


  17 in total

1.  Cellular response to prosthetic wear debris differs in patients with and without rheumatoid arthritis.

Authors:  Anant Vasudevan; Edward F DiCarlo; Timothy Wright; Dan Chen; Mark P Figgie; Steven R Goldring; Lisa A Mandl
Journal:  Arthritis Rheum       Date:  2011-11-29

2.  Influence of the loading frequency on the wear rate of a polyethylene-on-metal lumbar intervertebral disc replacement.

Authors:  Annette Kettler; Michael Bushelow; Hans-Joachim Wilke
Journal:  Eur Spine J       Date:  2010-10-10       Impact factor: 3.134

3.  A meta-analysis of minimally invasive and conventional medial parapatella approaches for primary total knee arthroplasty.

Authors:  Canfeng Li; Yi Zeng; Bin Shen; Pengde Kang; Jing Yang; Zongke Zhou; Fuxing Pei
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2014-01-22       Impact factor: 4.342

4.  [Thirteen-year results for the CLS expansion cup in primary hip arthroplasty].

Authors:  D Kendoff; C Strobel; C Krettek; T Gerich
Journal:  Unfallchirurg       Date:  2006-06       Impact factor: 1.000

5.  Do tissues from THA revision of highly crosslinked UHMWPE liners contain wear debris and associated inflammation?

Authors:  Ryan M Baxter; Theresa A Freeman; Steven M Kurtz; Marla J Steinbeck
Journal:  Clin Orthop Relat Res       Date:  2011-08       Impact factor: 4.176

Review 6.  Chronic inflammation in biomaterial-induced periprosthetic osteolysis: NF-κB as a therapeutic target.

Authors:  Tzu-hua Lin; Yasunobu Tamaki; Jukka Pajarinen; Heather A Waters; Deanna K Woo; Zhenyu Yao; Stuart B Goodman
Journal:  Acta Biomater       Date:  2013-10-01       Impact factor: 8.947

7.  Local effect of IL-4 delivery on polyethylene particle induced osteolysis in the murine calvarium.

Authors:  Allison J Rao; Christophe Nich; Lakshmi S Dhulipala; Emmanuel Gibon; Roberto Valladares; Stefan Zwingenberger; R Lane Smith; Stuart B Goodman
Journal:  J Biomed Mater Res A       Date:  2012-12-05       Impact factor: 4.396

8.  Distinct immunohistomorphologic changes in periprosthetic hip tissues from historical and highly crosslinked UHMWPE implant retrievals.

Authors:  Ryan M Baxter; Allyson Ianuzzi; Theresa A Freeman; Steven M Kurtz; Marla J Steinbeck
Journal:  J Biomed Mater Res A       Date:  2010-10       Impact factor: 4.396

9.  Direct subcutaneous injection of polyethylene particles over the murine calvaria results in dramatic osteolysis.

Authors:  Allison J Rao; Stefan Zwingenberger; Roberto Valladares; Chenguang Li; Robert Lane Smith; Stuart B Goodman; Christophe Nich
Journal:  Int Orthop       Date:  2013-04-21       Impact factor: 3.075

Review 10.  Acrylic bone cement: current concept review.

Authors:  B Magnan; M Bondi; T Maluta; E Samaila; L Schirru; C Dall'Oca
Journal:  Musculoskelet Surg       Date:  2013-07-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.